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The antifungal activities of acetone, hexane, dichloromethane and methanol leaf extracts of 24 South African Combretum species were
determined against five fungal animal pathogens (Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, Microsporum canis and
Sporothrix schenckii) representing yeasts, moulds and dimorphic fungi. MIC's determined after 48 h were usually two times higher than values
determined after 24 h. Most of the antifungal extracts had MIC values of c. 0.08 mg/ml, some with MIC values as low as 0.02 mg/ml. These are
substantially better values that reported in the literature to date. M. canis was the most susceptible microorganism followed by S. schenckii. A.
fumigatus was the most resistant of the pathogens tested. Methanol extracted the highest quantity from leaves, but the acetone extracts had the
highest antifungal activity in practically all cases. The methanolic extracts of C. moggii and C. petrophilum were however most active against all
the pathogens. All extracts of C. nelsonii were also very effective against all the pathogens. Based on these results and work done earlier, C.
nelsonii was selected for fractionation and bioassay-guided isolation of the antifungal compounds followed by C. albopuntactum, and C. imberbe.
© 2007 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Combretaceae; Combretum species; Antifungal activity; MIC1. Introduction
During the past decade there has been an increase in the
number of patients with weakened immune status associated with
human immunodeficiency virus (HIV). This has been associated
with an increase in the incidence of human systemic mycoses.
Even in a rich country such as the USA the number of deaths due
tomycoses increased from 1557 in 1980 to 6534 in 1997 (McNeil
et al., 2001; White et al., 1998). In spite of their expense,
Amphotericin B and the azole group of antifungal agents are
extensively used in the treatment of fungal infections. Unfortu-
nately, the widespread and incorrect use of these antifungals hasAbbreviations: AMB, amphotericin B; DCM, dichloromethane; EMW,
Ethyl acetate/methanol/water (40/5.4/4); CEF, Chloroform/ethyl acetate/formic
acid (5/4/1); BEA, Benzene/ethanol/ammonium hydroxide (90/10/1); INT,
p-iodonitrotetrazolium violet.
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0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2006.09.010led to the emergence of drug resistance in several common
pathogenic fungi (Graybill, 1996). Due to this emergence of
antibiotic resistant human pathogenic fungi, it is important to
develop new antifungal agents. The field of ethnobotanical
research has expanded greatly in recent years. Plants may yield
valuable antimicrobials.
In South Africa plants are widely used by all sections of the
population either directly as folk remedies or in different
indigenous systems of medicine or indirectly in the pharmaceu-
tical preparations of modern medicines. Plants used in traditional
medicine may constitute an important source of new biologically
active compounds.
Traditional healers throughout Africa use species of the
Combretaceae for many medicinal purposes. This includes
treating fever, headaches, abdominal disorders, abdominal
pains, gallstones, diarrhoea, dysentery, gastric ulcers, bilharziasis,
hookworm, nosebleeds, sore throats, colds, chest coughs,
pneumonia, conjunctivitis, dysmenorrhoea, infertility in
women, venereal diseases including syphilis, earache, fattening
babies, leprosy, scorpion and snake bites, swelling caused byts reserved.
Table 1
Combretum species used for antifungal screening
Combretum L
Section Species
Hypocrateropsis Engl. & Diels C. celastroides Welw. Ex Laws
(i) C. celastroides ssp. celastroides
(ii) C. celastroides ssp. orientale
C. imberbe Wawra
C. padoides Eng. & Diels
Angustimarginata Engl. & Diels C. caffrum (Eckl. & Zeyh) Kuntze
C. erythrophyllum (Burch.) Sond.
C. kraussii Hochst
C. woodii Duemmer
C. nelsonii Duemmer
Metallicum Excell & Stace C. collinum Fresen
(i) C. collinum ssp. suluense
(ii) C. collinum ssp. taborense
Spathulipetala Engl. & Diels C. zeyheri Sond.
Ciliatipetala Engl. & Diels C. albopunctactum Suesseng.
C. apiculatum Sond.
(i) C. apiculatum ssp. apiculatum
C. edwardsii Exell
C. moggii Excell
C. molle R. Br.
C. petrophilum Retief
Breviramea Engl. & Diels C. hereroense Schinz
Conniventia Engl. & Diels C. microphyllum Klotzsch
C. paniculatum Vent.
Poivrea (Comm. Ex DC) C. bracteosum (Hochst)
C. mossambicense (Klotzsch)
C. acutifolium
Infra-generic classification from Carr (1988).
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backache, jaundice, stomach and gastric problems, blennorrhagia,
constipation and general weakness (Hutchings et al., 1996;
Neuwinger, 1996; Iwu, 1993; Bever, 1986). Some of these uses
may be attributed to antifungal activity of extracts.
The Combretaceae consists of 18 genera, the largest of which
are Combretum, with about 370 species, and Terminalia, with
about 200 species (Lawrence, 1951). Species from the genus
Combretum and to a lesser extent Terminalia are most widely
used for medicinal purposes. As they are common and widely
distributed throughout western and southern Africa, (Rogers and
Verotta, 1996), they are readily available for use. The leaves and
bark of the Combretum species are predominantly used.
In Alexandra et al., 1992 found several antimicrobial
compounds in 12 different Combretum species. Martini and
Eloff (1998) found evidence for at least 14 unidentified bacterial
inhibitors from the leaves of Combretum erythrophyllum. Eloff
(1999) quantified the antibacterial activities of the leaf extracts of
27 members of Combretaceae, and in 2002 Fyhrquist et al. found
activity in extracts of the roots and stembark of Combretum and
Terminalia species used in Tanzania. The antibacterial properties
of Combretum species (Silva et al., 1996; Baba-Moussa et al.,
1999) have been well investigated, this is not the case regarding
their antifungal properties (Bhatt and Saxena, 1979; Baba-
Moussa et al., 1999). Our aim in this work is to address this gap by
investigating the antifungal activities of 24 Combretum species
occurring in southern Africa. We have shown that extracts
of South African Terminalia species (another member of the
Combretaceae) have substantial antifungal activities, with MIC's
as low as 20 μg/ml (Masoko et al., 2005).
Resistance to azole compounds, especially among Candida
species, has been well investigated over the past few years. As a
consequence of the AIDS epidemic, during the past decade there
was a striking increase in mucosal infections caused by Candida
species that was associated with a worrying emergence of
resistance to azoles. Primary resistance to amphotericin B has
emerged in parallel with the increase in the number of invasive
infections due to the so-called emerging fungi. Usually included
in these emerging fungi are yeasts such as Trichosporon beigelii,
C. lusitaniae or C. guillermondii. Many of these fungi show
primary or intrinsic resistance to amphotericin B, and may cause
invasive infections, usually associated with a high mortality
(Tritz and Woods, 1993). Although C. glabrata and C. krussei
are usually considered to be susceptible to amphotericin B, they
tend to have higher MIC's to polyenes than C. albicans, and a
growing body of data suggests that a significant proportion of
isolates of both species can be resistant to amphotericin B (Rex
et al., 2000).
There is still a high mortality associated with some invasive
fungal infections, especially those produced by filamentous fungi.
Most antifungal agents are expensive and have serious side
effects. Other sources of antifungal agents should also be
investigated. Hostettmann et al. (2000) stressed the importance
of investigating plants for new antifungal agents. The aim of this
report is to investigate the antifungal activity of different leaf
extracts of 24 Combretum species in order to determine which
species have good potential as antifungal agents.2. Materials and methods
2.1. Plant collection
Leaves were collected, in Summer, from plants in the
Lowveld National Botanical Garden in Nelspruit in 2003.
Voucher specimens and origins of the trees are kept in garden
herbarium. Plants used are listed in Table 1 below. More
information on the origin and references of these plants are
presented elsewhere (Eloff, 1999).
2.2. Plant drying and storage
Leaves were separated from stems, and dried at room
temperature. Most scientists have tended to use dried material
because there are fewer problems associated with large scale
extraction of dried plants rather than fresh plant material (Eloff,
1998a). The dried plants were milled to a fine powder in a
Macsalab mill (Model 200 LAB), Eriez®, Bramley, and stored
at room temperature in closed containers in the dark until used.
2.3. Extraction procedure
Plant samples from each species were individually extracted
by weighing four aliquots of 1 g of finely ground plant material
and extracting with 10 ml of acetone, hexane, dichloromethane
175P. Masoko et al. / South African Journal of Botany 73 (2007) 173–183(DCM) or methanol (technical grade-Merck) in centrifuge tubes.
These tubes were vigorously shaken for 3–5 min in a Labotec
model 20.2 shakingmachine at high speed. After centrifugation at
3500 rpm for 10 min the supernatant was decanted into labelled
containers. This process was repeated 3 times to exhaustively
extract the plant material and the extracts were combined. The
solvent was removed under a stream of air in a fume cupboard at
room temperature before dissolving extracts in acetone to a
concentration of 10 mg/ml, to quantify the assay. Preliminary
experiments have shown that acetone diluted according the MIC
bioassay procedure does not inhibit the growth of any of the fungi
tested (Manuscript by Eloff and Masoko in preparation).
2.4. Phytochemical analysis
Chemical constituents of the extracts were analyzed by thin
layer chromatography (TLC) using aluminium-backed TLC
plates (Merck, silica gel 60 F254). The TLC plates were developed
with one of the three eluent systems developed in our laboratory
that separate components of Combretaceae extracts well i.e. ethyl
acetate/methanol/water (40:5.4:5): [EMW] (polar/neutral); chlo-
roform/ethyl acetate/formic acid (5:4:1): [CEF] (intermediate
polarity/acidic); Benzene/ethanol/ammonium hydroxide
(90:10:1): [BEA] (non-polar/basic) (Kotze and Eloff, 2002).
Development of the chromatograms was in a closed tank inwhich
the atmosphere had been saturated with the eluent vapor by lining
the tank with filter paper wetted with the eluent.
To detect the chemical components of each extract, vanillin-
sulphuric acid (0.1 g vanillin (Sigma): 28 ml methanol: 1 ml
sulphuric acid) was sprayed on the chromatograms and heated at
110 °C to optimal colour development.Fig. 1. Total percentage ofCombretum species extracted by acetone , hexane▪, dichclassification (Carr, 1988).2.5. Fungal test organisms
Five fungi were obtained from the bacteriology laboratory,
Department of Veterinary Tropical Diseases, Faculty of Veteri-
nary Science and used as test organisms. These fungi represent
the different morphological forms of fungi, namely yeasts
(Candida albicans and Cryptococcus neoformans), thermally
dimorphic fungi (Sporothrix schenckii) and moulds (Aspergillus
fumigatus and Microsporum canis) and are the most common
and important disease-causing fungi of animals. C. albicans was
isolated from a Goldian finch, C. neoformans from a cheetah,
and A. fumigatus from a chicken, all of which suffered from
a systemic mycosis. M. canis was isolated from a cat with
dermatophytosis and S. schenckii from a horse with cutaneous
lymphangitis. Not one of the animals had been treated prior to
sampling. All fungal strains were maintained on Sabouraud
dextrose agar (Oxoid, Basingstoke, UK).
2.6. Antifungal assays
2.6.1. Microdilution assay
A serial microdilution assay (Eloff, 1998c) was used to
determine the minimum inhibitory concentration (MIC) values
for plant extracts using tetrazolium violet reduction as an
indicator of growth. This method had previously been used only
for antibacterial activities (Eloff, 1998c; McGaw et al., 2001).
To apply it to measuring antifungal activities, a slight
modification was made to suit fungal growth conditions.
Residues of the different extracts were dissolved in acetone to
a concentration of 10 mg/ml. The plant extracts (100 μl) were
serially diluted 50% with water in 96-well microtitre platesloromethane , and methanol . Order from left to right represents infra-generic
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Table 4
Average MIC values of different Combretum species after 24 and 48 h
incubation of all extracts against all test pathogens
Combretum species Average MIC values (mg/ml)
24 and 48 h 24 h 24 h a 48 h 48 h a
C. celastroides ssp. celestroides 0.34 0.28 0.23 0.4 0.32
C. celastroides ssp. orientale 0.43 0.32 0.15 0.54 0.18
C. imberbe 0.74 0.57 0.17 0.9 0.28
C. padoides 0.54 0.29 0.27 0.62 0.35
C. caffrum 0.39 0.36 0.27 0.43 0.35
C. erythrophyllum 0.8 0.65 0.49 0.95 0.57
C. kraussii 0.56 0.4 0.43 0.72 0.54
C. woodii 0.55 0.36 0.29 0.74 0.46
C. collinum ssp. suluense 0.85 0.61 0.39 1.08 0.73
C. collinum ssp. taborense 0.65 0.5 0.28 0.79 0.43
C. zeyheri 0.53 0.28 0.13 0.78 0.35
C. albopunctatum 0.59 0.28 0.28 0.89 0.49
C. apiculatum ssp. apiculatum 0.41 0.18 0.05 0.64 0.17
C. edwardsii 0.48 0.23 0.22 0.73 0.29
C. moggi 0.53 0.33 0.22 0.72 0.27
C. molle 0.48 0.31 0.13 0.66 0.27
C. petrophilum 0.65 0.37 0.06 0.93 0.53
C. hereroense 0.48 0.28 0.07 0.67 0.3
C. microphyllum 0.85 0.53 0.27 1.16 0.83
C. paniculatum 0.87 0.61 0.33 1.14 0.8
C. bracteosum 0.57 0.19 0.05 0.96 0.57
C. mossambicense 0.67 0.19 0.06 1.14 0.8
C. acutifolium 0.26 0.05 0.04 0.47 0.41
C. nelsonii 0.22 0.09 0.07 0.37 0.15
Average 0.56 0.34 0.21 0.77 0.44
a Without A. fumigatus.
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Sabouraud dextrose broth, and 100 μl of this was added to each
well. Amphotericin B was used as the reference antibiotic and
positive control, and appropriate solvent blanks were included
as negative control. As an indicator of growth, 40 μl of 0.2 mg/
ml of p-iodonitrotetrazolium violet (Sigma®) (INT) dissolved
in water was added to each of the microplate wells. The covered
microplates were incubated for 2 to 3 days at 35 °C and 100%
relative humidity. The MIC was recorded as the lowest
concentration of the extract that inhibited antifungal growth
after 24 and 48 h.
One is tempted to consider the 48 h value as a minimal
fungicidal concentration especially since no growth was apparent
in the particular well after 120 h. When cells from wells showing
no growth after 48 h were incubated in fresh growth medium,
however fungal growth resumed. The inhibition therefore appears
to be fungistatic rather than fungicidal at the levels tested. Motsei
et al. (2003) used a different technique to determineMIC values of
medicinal plants traditionally used against C. albicans infections
and it was not possible to distinguish between fungistatic and
fungicidal activities.
3. Results and discussion
Twenty-four Combretum species were selected for antifungal
activity screening based on their use in traditional medicinal
treatments for both domestic animals and humans and
availability in southern Africa. Success in isolating compounds
from plant material is largely dependent on the type of the
solvent used in the extraction procedure (Lin et al., 1999). The
total percentages extracted using different solvents (acetone,
hexane, DCM and methanol) are shown in Fig. 1. Methanol was
the quantitatively the best extractant, extracting a greater
quantity of plant material than any of the other solvents. Total
percentages extracted with methanol of C. apiculatum sub-
species apiculatum, C. petrophilum, C. hereroense and C.
microphyllum were between 25 and 41%. Hexane and
dichloromethane are more selective extractants for Combre-
tum species, because for all the species, the total percentage
extracted was below 5% (Fig. 1). The total percentage extracted
with acetone was better in 10 of the Combretum species tested,
ranging from 5 to 21%.
After evaporation of extracting solvents, the hexane,
dichloromethane and methanol extracts were redissolved in
acetone because this solvent was found not to be harmful
towards bacteria (Eloff, 1998b). We found that acetone was also
not harmful towards fungi at the final concentration (25%) the
fungi were subjected to (manuscript by Eloff and Masoko in
preparation). Of the four solvents used, methanol extracted
more chemical compounds from leaves of the Combretum
species, but the extract probably contained highly polar
compounds and tannins that may not be that interesting for
clinical application.
The separated compounds on TLC plates were made visible
by spraying with vanillin-sulphuric acid. There was some
similarity in the chemical composition of the non-polar
components of extracts using extractants of varying polarity.MIC values were determined by checking growth after 24
and 48 h to determine the end point. The MIC values of most of
the extracts were in the order of 0.08 mg/ml and some had
values as low as 0.02 mg/ml, especially against C. neoformans,
S. schenckii and M. canis (Table 2). The methanolic extracts of
C. moggii and C. petrophilum were very active against all the
tested pathogens. All extracts of C. nelsonii were very effective
against all the pathogens. Acetone and methanol extracts of C.
acutifolium were active against all pathogens after 24 h of
incubation, with MIC values ranging from 0.02 and 0.04 mg/ml.
Only the MIC against A. fumigatus increased to 0.16 mg/ml
after 48 h. The acetone extracts of C. molle and C. celastroides
ssp. orientale were the most active against all the fungi tested as
they had average MIC values, of 0.19 and 0.13 mg/ml
respectively.
The hexane extracts of C. collinum ssp. suluense, C.
microphyllum, C. paniculatum, and the methanolic extracts of
C. erythrophyllum, C. woodii, and the dichloromethane extract
of C. petrophilum were the least active against all the fungi
tested as the MIC values ranged from 1.01 to 1.89 mg/ml.
To determine which plants can be used for further testing and
isolation, not only the MIC value is important, but also the total
activity (Eloff, 1999). Because the MIC value is inversely
related to the quantity of antifungal compounds present, an
arbitrary measure of the quantity of antifungal compounds
present was calculated by dividing the quantity extracted in mg
from 1 g leaves by the MIC value in mg/ml. This total activity
(Table 3) value indicates the volume to which the biologically
Fig. 3. The average antifungal activity of different leaf extracts of 24 Combre-
tum species towards C. albicans , C. neoformans , A. fumigatus □,
S. schenckii , and M. canis after 24 h (A) and 48 h (B).
Fig. 2. The sensitivity of different fungal pathogens in ml/mg to acetone ,
hexane ▪, dichloromethane , and methanol extracts of 24 Combretumspecies (antifungal activity expressed as inverse of MIC in mg/ml) after 24 h (A)
and 48 h (B).
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be diluted and still kill the fungi (Eloff, 1999).
Extracts with higher activity were considered the best to
work with, from Table 3 M. canis was the most sensitive of all
the organisms tested and all 96 extracts inhibited the growth at
low concentrations 0.02 to 0.04 mg/ml. A fumigatus had a
higher resistance against all plant extracts with the exception of
C. kraussii (methanol), C. apiculatum ssp. apiculatum (acetone
and methanol), C. edwardsii (acetone), C. moggii (methanol)
and C. acutifolium (acetone, dichloromethane and methanol)
extracts. After 48 h of incubation the situation changed. Only
C. kraussii extracts had a better activity after 48 h. Average MIC
values of all Combretum species were calculated (Table 4) after
24 and 48 h incubation with and without A. fumigatus, because
results with this organism differed much compared to that
with other fungi (Tables 2 and 3).
The average MIC values of all Combretum species using all
pathogens after 24 h was 0.34 mg/ml and after the results against
A. fumigatus were excluded, it was 0.21 mg/ml (Table 4). After
48 h there was a difference in the average MIC values of
0.33 mg/ml. Although there was inhibition of the A. fumigatus
after 24 h of incubation, this inhibition was overcame after 48 h
of incubation. This could be due to a breakdown of the active
antifungal compounds allowing the inhibited fungus to grow, orthe fungusmay have been able to overcome the inhibitory effects
of the antifungal compound(s) with time.
Amphotericin B was used as a positive control to ensure that
the test was functioning properly. This was the case as all the
fungi tested had MIC's of b0.02 mg/ml. In subsequent
experiments with lower concentrations of amphotericin B,
the MIC's for C. albicans, C. neoformans variety gattii,
S. schenckii and M. canis were 0.4, 0.3, 0.4, and 0.2 μg/ml
respectively after 48 h incubation and for A. fumigatus it was
0.2 μg/ml after 24 h. All the tested pathogens were sensitive to
different Combretum species extracted with different solvent
systems (Fig. 2). The methanol and acetone extracts (Fig. 3)
were generally the most active, followed by dichloromethane.
Hexane extracts were the least active.
C. nelsonii was selected for fractionation and bioassay-
guided isolation of the antifungal compounds because the crude
extracts had low average MIC values in acetone, hexane, DCM
and methanol i.e. (0.12, 0.38, 0.21 and 0.16 mg/ml respectively)
and high total activities (i.e. 1456, 1257, 594 and 1680 ml/g)
respectively. The next best species was C. albopuntactum with
average MIC values of 0.44, 0.88, 0.50 and 0.32 mg/ml
respectively and total activities of 582, 384, 499 and 660 ml
respectively. The third best was C. imberbe with average MIC
values of 0.95, 0.79, 0.49 and 0.71 mg/ml and total activities of
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tion between subgeneric classification and antifungal activities
(Fig. 1). These species were also selected because they have
not previously been investigated for antifungal activity.
Baba-Moussa et al. (1999) investigated the antifungal
activities of sevenWest African Combretaceae used in traditional
medicine, (Combretum glutinosum, C. hispidum, C. molle, C.
nigricans and some Terminalias (T. avicennioides and T. mollis)
on five pathogenic fungi, which were Epidermophyton flocco-
sum, Microsporum gypseum, Trichophyton mentagrophytes, Tri-
chophyton rubrum andC. albicans. Their MIC values were in the
range of 0.25–4mg/ml, T. mentagrophyteswas the most sensitive
fungus on average. Fyhrquist et al. (2002) have found evidence
that some of the 12 different Combretum species tested had
antifungal activities. Motsei et al. (2003) have tested number of
plants on C. albicans but their results of MIC values were very
high (N25 mg/ml).
Some authors have determined antifungal activities and MIC
using different plant species. Their MIC values were generally
high. Delaporte et al. (2004) used Tillandsia streptocarpa
(Bromeliaceae) to test antimicrobial activity on C. albicans
(MICN0.5mg/ml), Chandrasekaran andVenkatesalu (2004) have
found that seed extracts of Syzgium jambolanum were effective
against different pathogens, C. albicans, C. neoformans, A.
fumigatus and M. gypseum with the MIC values of 0.62, 0.25,
0.125 and 0.25 mg/ml respectively, and Chamundeeswari et al.
(2004) found antifungal activity ofTrewia polycarpa root extracts
on C. albicans, A. niger, C. neoformans and Penicillum sp.
Alcoholic extracts had mild antifungal activity with MIC values
of 0.25, 0.25, 0.125 and 0.313 mg/ml respectively. When
comparing the MIC values with our data it is clear that extracts
of Combretum species have substantial activity against fungal
pathogens.
We have also shown that there are a number of active
compounds against fungi present in Terminalia species (Masoko
and Eloff, 2005). From the Rf values in bioautography data and
activity in non-polar and intermediate polarity extracts it appears
that antifungal activity may not only be attributable to tannins
found in Combretum spp. as was previously postulated (Baba-
Moussa et al., 1999). The results obtained here are in line with the
low MIC values obtained in different extracts of Terminalia spp.
(Masoko et al., 2005).
4. Conclusion
The results of the present work indicate that the Combretum
species assayed possess substantial antifungal properties. If there
are no synergistic effects and the antifungal compounds comprise
0.1% of the mass [in our experience this is a reasonable rule of
thumb for compounds in some members of the Combretaceae],
the antifungal compound may have an MIC of 0.02 to 0.2 μg/ml
compared to MIC's of 0.2–0.4 μg/ml of amphotericin B for these
pathogens. The results of this study support several of the
traditional medicinal uses ofCombretum species all over southern
Africa and in the whole continent. The isolation and character-
ization of three compounds with excellent antifungal activities
from C. nelsonii as well as the in vivo activity of isolatedcompounds and several extracts on rats are reported elsewhere
(Masoko, 2006).
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